We are live on
!
Find out more
HCMT
Highland Capital Management (Texas) Portfolio holdings
AUM
$39M
This Fund
S&P 500
This Quarter
Est. Return
+4.26%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.5B
AUM Growth
+$672M
(+37%)
Cap. Flow
+$701M
Cap. Flow
% of AUM
28.01%
Top 10 Holdings %
Top 10 Hldgs %
37.99%
Holding
272
New
82
Increased
63
Reduced
33
Closed
62
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
American Airlines Group
AAL
|
+$188M |
| 2 |
TFM
THE FRESH MARKET, INC COM STK
TFM
|
+$61.7M |
| 3 |
SPLS
Staples Inc
SPLS
|
+$60.7M |
| 4 |
ProShares Ultra Silver
AGQ
|
+$46.9M |
| 5 |
News Corp Class A
NWSA
|
+$24.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GNC
GNC Holdings, Inc.
GNC
|
+$25.5M |
| 2 |
Apple
AAPL
|
+$20.2M |
| 3 |
Western Digital
WDC
|
+$20M |
| 4 |
Meta Platforms (Facebook)
META
|
+$15.6M |
| 5 |
FedEx
FDX
|
+$15.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 15.44% |
| 2 | Technology | 12.56% |
| 3 | Communication Services | 12.54% |
| 4 | Financials | 11.15% |
| 5 | Healthcare | 10.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EXAM
126
DELISTED
EXAMWORKS GROUP INC COM STK (DE)
EXAM
| $2.23M | 0.09% |
63,701
+31,358
| +97% | +$1.02M |
|
127
Vanda Pharmaceuticals
VNDA
$304M
| $2M | 0.08% |
+123,090
| New | +$1.75M |
|
128
Medtronic
MDT
$114B
| $1.95M | 0.08% |
+31,670
| New | +$1.84M |
|
|
WBMD
129
DELISTED
WebMD Health Corp.
WBMD
| $1.83M | 0.07% |
44,222
+28,970
| +190% | +$1.31M |
|
130
Spectrum Brands
SPB
$2.02B
| $1.8M | 0.07% |
22,620
+17,120
| +311% | +$1.28M |
|
|
INVN
131
DELISTED
Invensense Inc
INVN
| $1.77M | 0.07% |
+75,000
| New | +$1.57M |
|
|
CVSA
132
Covista Inc
CVSA
$4.38B
| $1.76M | 0.07% |
41,425
-133,675
| -76% | -$5.17M |
|
|
PGTI
133
DELISTED
PGT, Inc.
PGTI
| $1.73M | 0.07% |
+150,000
| New | +$1.68M |
|
|
ARRS
134
DELISTED
ARRIS International plc Ordinary Shares
ARRS
| $1.69M | 0.07% |
+60,000
| New | +$1.64M |
|
135
Edwards Lifesciences
EW
$53B
| $1.68M | 0.07% |
135,600
| – | – |
|
136
Acadia Pharmaceuticals
ACAD
$5.06B
| $1.65M | 0.07% |
67,833
+22,833
| +51% | +$578K |
|
|
CMRX
137
DELISTED
Chimerix, Inc.
CMRX
| $1.6M | 0.06% |
70,191
+56,082
| +397% | +$1.13M |
|
138
Option Care Health
OPCH
$3.67B
| $1.51M | 0.06% |
54,124
+26,124
| +93% | +$807K |
|
|
TMH
139
DELISTED
Team Health Holdings Inc
TMH
| $1.48M | 0.06% |
33,150
+22,421
| +209% | +$1.01M |
|
140
Galmed Pharmaceuticals
GLMD
$4.9M
| $1.46M | 0.06% |
+705
| New | +$1.65M |
|
|
EXAS
141
DELISTED
Exact Sciences
EXAS
| $1.42M | 0.06% |
+100,000
| New | +$1.35M |
|
|
APOL
142
DELISTED
Apollo Education Group Inc Class A
APOL
| $1.4M | 0.06% |
40,950
-32,600
| -44% | -$1.06M |
|
|
ICPT
143
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $1.39M | 0.06% |
4,210
-16,426
| -80% | -$5.54M |
|
|
KERX
144
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $1.36M | 0.05% |
80,000
+53,895
| +206% | +$813K |
|
|
RXII
145
DELISTED
GALENA BIOPHARMA INC COM
RXII
| $1.32M | 0.05% |
528,027
+252,300
| +92% | +$631K |
|
146
Neurocrine Biosciences
NBIX
$16.8B
| $1.29M | 0.05% |
+80,000
| New | +$1.37M |
|
147
Biogen
BIIB
$30.6B
| $1.28M | 0.05% |
4,179
-535
| -11% | -$170K |
|
|
HES
148
DELISTED
Hess
HES
| $1.24M | 0.05% |
14,910
-16,245
| -52% | -$1.29M |
|
149
Anika Therapeutics
ANIK
$277M
| $1.23M | 0.05% |
+30,000
| New | +$1.12M |
|
150
Generac Holdings
GNRC
$12.2B
| $1.18M | 0.05% |
+20,000
| New | +$1.09M |
|
Similar funds
DHRFI
TG
QVT
KA
AC
FRGX
SA
YECIP
Highland Capital Management (Texas)'s Q1 2014 Portfolio in Review
As of Q1 2014, Highland Capital Management (Texas) held 272 positions worth $2.5B, up 37% from $1.83B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Highland Capital Management (Texas) deployed $701M of net new capital in Q1 2014, opening 82 new positions and adding to 63 existing holdings. Its largest new stake was THE FRESH MARKET, INC COM STK: 1,752,474 shares worth $58.9M.
By sector, the portfolio is most concentrated in Industrials at 15% of assets, up from 9.6% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was GNC Holdings, Inc., an estimated $25.5M trimmed.
- Highland Capital Management (Texas)'s largest Q1 2014 buy was THE FRESH MARKET, INC COM STK: 1,752,474 shares worth $58.9M.
- Highland Capital Management (Texas) added most to American Airlines Group in Q1 2014, an estimated $188M increase.
- Highland Capital Management (Texas)'s biggest Q1 2014 reduction was GNC Holdings, Inc., cutting an estimated $25.5M.
- Highland Capital Management (Texas) fully exited Apple in Q1 2014, selling an estimated $20.2M.
- Highland Capital Management (Texas)'s ten largest holdings make up 38% of its $2.5B portfolio in Q1 2014.
- Highland Capital Management (Texas) opened 82 new positions and closed 62 in Q1 2014.
- Highland Capital Management (Texas)'s portfolio value rose 37% quarter-over-quarter to $2.5B.
Based on Highland Capital Management (Texas)'s 13F filing for Q1 2014, filed 15 May 2014.